nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—peripheral nervous system neoplasm—germ cell cancer	0.322	1	CtDrD
Tretinoin—NR0B1—germ cell cancer	0.217	0.591	CbGaD
Tretinoin—CRABP1—germ cell cancer	0.151	0.409	CbGaD
Tretinoin—CYP4A11—Cisplatin—germ cell cancer	0.0406	0.226	CbGbCtD
Tretinoin—CYP2C18—Ifosfamide—germ cell cancer	0.0366	0.204	CbGbCtD
Tretinoin—CYP2A6—Ifosfamide—germ cell cancer	0.0178	0.0993	CbGbCtD
Tretinoin—CYP3A7—Ifosfamide—germ cell cancer	0.0122	0.0679	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0122	0.0679	CbGbCtD
Tretinoin—CYP2B6—Ifosfamide—germ cell cancer	0.0116	0.0646	CbGbCtD
Tretinoin—CYP3A5—Ifosfamide—germ cell cancer	0.00913	0.0509	CbGbCtD
Tretinoin—CYP2C8—Ifosfamide—germ cell cancer	0.00877	0.0489	CbGbCtD
Tretinoin—CYP2C9—Ifosfamide—germ cell cancer	0.00612	0.0341	CbGbCtD
Tretinoin—CYP2B6—Cisplatin—germ cell cancer	0.00563	0.0314	CbGbCtD
Tretinoin—CYP3A5—Etoposide—germ cell cancer	0.00436	0.0243	CbGbCtD
Tretinoin—CYP2C8—Etoposide—germ cell cancer	0.00419	0.0234	CbGbCtD
Tretinoin—CYP3A4—Ifosfamide—germ cell cancer	0.00356	0.0198	CbGbCtD
Tretinoin—NR0B1—seminiferous tubule of testis—germ cell cancer	0.00342	0.0886	CbGeAlD
Tretinoin—CYP2C9—Cisplatin—germ cell cancer	0.00298	0.0166	CbGbCtD
Tretinoin—Alitretinoin—CRABP1—germ cell cancer	0.00192	1	CrCbGaD
Tretinoin—CYP3A4—Vinblastine—germ cell cancer	0.00189	0.0105	CbGbCtD
Tretinoin—CRABP2—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.00171	0.0557	CbGpPWpGaD
Tretinoin—CYP3A4—Etoposide—germ cell cancer	0.0017	0.00949	CbGbCtD
Tretinoin—CRABP2—Regulation of pyruvate dehydrogenase (PDH) complex—CRABP1—germ cell cancer	0.00144	0.0472	CbGpPWpGaD
Tretinoin—ALDH1A2—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.0012	0.0391	CbGpPWpGaD
Tretinoin—CYP2C9—cardial valve—germ cell cancer	0.00115	0.0298	CbGeAlD
Tretinoin—CRABP2—Pyruvate metabolism—CRABP1—germ cell cancer	0.00104	0.0341	CbGpPWpGaD
Tretinoin—RARG—Nuclear Receptors—NR0B1—germ cell cancer	0.00103	0.0336	CbGpPWpGaD
Tretinoin—CRABP2—pineal body—germ cell cancer	0.000975	0.0253	CbGeAlD
Tretinoin—RXRG—Nuclear Receptors—NR0B1—germ cell cancer	0.00094	0.0307	CbGpPWpGaD
Tretinoin—RARB—Nuclear Receptors—NR0B1—germ cell cancer	0.000922	0.0301	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptors—NR0B1—germ cell cancer	0.000884	0.0289	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptors—NR0B1—germ cell cancer	0.000884	0.0289	CbGpPWpGaD
Tretinoin—ALDH1A1—Dopaminergic Neurogenesis—SOX2—germ cell cancer	0.000851	0.0278	CbGpPWpGaD
Tretinoin—CRABP2—skin epidermis—germ cell cancer	0.000831	0.0215	CbGeAlD
Tretinoin—RARG—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000812	0.0266	CbGpPWpGaD
Tretinoin—RXRG—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000743	0.0243	CbGpPWpGaD
Tretinoin—RARB—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000729	0.0238	CbGpPWpGaD
Tretinoin—RXRG—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00072	0.0235	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000698	0.0228	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000698	0.0228	CbGpPWpGaD
Tretinoin—RXRA—ganglion—germ cell cancer	0.000697	0.018	CbGeAlD
Tretinoin—ALDH1A1—Podofilox—Etoposide—germ cell cancer	0.000692	0.5	CbGdCrCtD
Tretinoin—ALDH1A1—Teniposide—Etoposide—germ cell cancer	0.000692	0.5	CbGdCrCtD
Tretinoin—RXRB—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.000677	0.0221	CbGpPWpGaD
Tretinoin—ALDH1A1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000655	0.0214	CbGpPWpGaD
Tretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000655	0.0214	CbGpPWpGaD
Tretinoin—CRABP2—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.000631	0.0206	CbGpPWpGaD
Tretinoin—RXRA—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.000516	0.0169	CbGpPWpGaD
Tretinoin—RARRES1—trigeminal ganglion—germ cell cancer	0.000513	0.0133	CbGeAlD
Tretinoin—RXRG—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000472	0.0154	CbGpPWpGaD
Tretinoin—RXRA—Nuclear Receptors—NR0B1—germ cell cancer	0.000461	0.0151	CbGpPWpGaD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000443	0.0145	CbGpPWpGaD
Tretinoin—RARG—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000442	0.0145	CbGpPWpGaD
Tretinoin—CRABP1—neck—germ cell cancer	0.00044	0.0114	CbGeAlD
Tretinoin—RXRA—Regulation of pyruvate dehydrogenase (PDH) complex—CRABP1—germ cell cancer	0.000437	0.0143	CbGpPWpGaD
Tretinoin—RXRG—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000405	0.0132	CbGpPWpGaD
Tretinoin—RARB—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000397	0.013	CbGpPWpGaD
Tretinoin—RARRES1—skin of body—germ cell cancer	0.000385	0.00997	CbGeAlD
Tretinoin—RARRES1—decidua—germ cell cancer	0.000382	0.0099	CbGeAlD
Tretinoin—RARA—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00038	0.0124	CbGpPWpGaD
Tretinoin—RXRB—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00038	0.0124	CbGpPWpGaD
Tretinoin—ALDH1A2—embryo—germ cell cancer	0.00038	0.00985	CbGeAlD
Tretinoin—CRABP1—trigeminal ganglion—germ cell cancer	0.00038	0.00984	CbGeAlD
Tretinoin—CRABP1—embryo—germ cell cancer	0.000367	0.0095	CbGeAlD
Tretinoin—RXRA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000364	0.0119	CbGpPWpGaD
Tretinoin—RXRA—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.000353	0.0115	CbGpPWpGaD
Tretinoin—RXRG—neck—germ cell cancer	0.000348	0.00901	CbGeAlD
Tretinoin—CRABP2—trigeminal ganglion—germ cell cancer	0.000344	0.0089	CbGeAlD
Tretinoin—CRABP1—brainstem—germ cell cancer	0.000336	0.00871	CbGeAlD
Tretinoin—RARRES1—uterus—germ cell cancer	0.000334	0.00866	CbGeAlD
Tretinoin—CRABP2—embryo—germ cell cancer	0.000332	0.0086	CbGeAlD
Tretinoin—ALDH1A1—neck—germ cell cancer	0.000332	0.00859	CbGeAlD
Tretinoin—RARRES1—pituitary gland—germ cell cancer	0.000328	0.0085	CbGeAlD
Tretinoin—CRABP1—eye—germ cell cancer	0.000327	0.00848	CbGeAlD
Tretinoin—CYP2C18—Metapathway biotransformation—NAT9—germ cell cancer	0.000326	0.0107	CbGpPWpGaD
Tretinoin—CRABP1—retina—germ cell cancer	0.000324	0.0084	CbGeAlD
Tretinoin—RXRA—Pyruvate metabolism—CRABP1—germ cell cancer	0.000316	0.0103	CbGpPWpGaD
Tretinoin—RXRG—trigeminal ganglion—germ cell cancer	0.0003	0.00778	CbGeAlD
Tretinoin—CRABP2—eye—germ cell cancer	0.000296	0.00767	CbGeAlD
Tretinoin—RARRES1—adrenal gland—germ cell cancer	0.000293	0.0076	CbGeAlD
Tretinoin—ALDH1A2—decidua—germ cell cancer	0.000293	0.00759	CbGeAlD
Tretinoin—NR0B1—gonad—germ cell cancer	0.00029	0.0075	CbGeAlD
Tretinoin—ALDH1A1—trigeminal ganglion—germ cell cancer	0.000286	0.00742	CbGeAlD
Tretinoin—CRABP1—skin of body—germ cell cancer	0.000285	0.00738	CbGeAlD
Tretinoin—NR0B1—pituitary gland—germ cell cancer	0.000283	0.00732	CbGeAlD
Tretinoin—ALDH1A1—embryo—germ cell cancer	0.000277	0.00716	CbGeAlD
Tretinoin—RARRES1—female gonad—germ cell cancer	0.000273	0.00708	CbGeAlD
Tretinoin—RXRA—telencephalon—germ cell cancer	0.000269	0.00696	CbGeAlD
Tretinoin—RXRG—eye—germ cell cancer	0.000259	0.0067	CbGeAlD
Tretinoin—ALDH1A2—gonad—germ cell cancer	0.000258	0.00669	CbGeAlD
Tretinoin—CRABP2—skin of body—germ cell cancer	0.000258	0.00667	CbGeAlD
Tretinoin—ALDH1A2—uterus—germ cell cancer	0.000256	0.00664	CbGeAlD
Tretinoin—CRABP2—decidua—germ cell cancer	0.000256	0.00663	CbGeAlD
Tretinoin—ALDH1A1—brainstem—germ cell cancer	0.000253	0.00656	CbGeAlD
Tretinoin—NR0B1—adrenal gland—germ cell cancer	0.000252	0.00654	CbGeAlD
Tretinoin—ALDH1A2—pituitary gland—germ cell cancer	0.000252	0.00652	CbGeAlD
Tretinoin—RARG—trigeminal ganglion—germ cell cancer	0.000251	0.00649	CbGeAlD
Tretinoin—CRABP1—gonad—germ cell cancer	0.000249	0.00645	CbGeAlD
Tretinoin—CYP2C9—urine—germ cell cancer	0.000248	0.00642	CbGeAlD
Tretinoin—ALDH1A1—eye—germ cell cancer	0.000247	0.00639	CbGeAlD
Tretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000245	0.00801	CbGpPWpGaD
Tretinoin—CRABP1—pituitary gland—germ cell cancer	0.000243	0.00629	CbGeAlD
Tretinoin—RARRES1—testis—germ cell cancer	0.000243	0.00628	CbGeAlD
Tretinoin—NR0B1—female gonad—germ cell cancer	0.000235	0.0061	CbGeAlD
Tretinoin—CRABP1—medulla oblongata—germ cell cancer	0.000234	0.00607	CbGeAlD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000231	0.00755	CbGpPWpGaD
Tretinoin—CRABP2—gonad—germ cell cancer	0.000225	0.00583	CbGeAlD
Tretinoin—ALDH1A2—adrenal gland—germ cell cancer	0.000225	0.00583	CbGeAlD
Tretinoin—ALDH1A1—telencephalon—germ cell cancer	0.000225	0.00582	CbGeAlD
Tretinoin—RXRB—telencephalon—germ cell cancer	0.000222	0.00574	CbGeAlD
Tretinoin—CRABP2—pituitary gland—germ cell cancer	0.00022	0.00569	CbGeAlD
Tretinoin—NR0B1—endocrine gland—germ cell cancer	0.000219	0.00567	CbGeAlD
Tretinoin—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.000217	0.00708	CbGpPWpGaD
Tretinoin—RARG—eye—germ cell cancer	0.000216	0.00559	CbGeAlD
Tretinoin—ALDH1A1—skin of body—germ cell cancer	0.000215	0.00556	CbGeAlD
Tretinoin—CRABP1—midbrain—germ cell cancer	0.000214	0.00555	CbGeAlD
Tretinoin—RARG—retina—germ cell cancer	0.000214	0.00554	CbGeAlD
Tretinoin—ALDH1A1—decidua—germ cell cancer	0.000213	0.00552	CbGeAlD
Tretinoin—CRABP2—medulla oblongata—germ cell cancer	0.000212	0.00549	CbGeAlD
Tretinoin—RXRB—decidua—germ cell cancer	0.00021	0.00545	CbGeAlD
Tretinoin—ALDH1A2—female gonad—germ cell cancer	0.00021	0.00543	CbGeAlD
Tretinoin—CRABP1—spinal cord—germ cell cancer	0.000209	0.00542	CbGeAlD
Tretinoin—NR0B1—testis—germ cell cancer	0.000209	0.00541	CbGeAlD
Tretinoin—CYP1A1—skin epidermis—germ cell cancer	0.000209	0.0054	CbGeAlD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000208	0.00681	CbGpPWpGaD
Tretinoin—RXRA—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000198	0.00648	CbGpPWpGaD
Tretinoin—CRABP2—adrenal gland—germ cell cancer	0.000196	0.00508	CbGeAlD
Tretinoin—ALDH1A2—endocrine gland—germ cell cancer	0.000195	0.00505	CbGeAlD
Tretinoin—ALDH1A2—head—germ cell cancer	0.000193	0.00499	CbGeAlD
Tretinoin—RXRG—pituitary gland—germ cell cancer	0.000192	0.00497	CbGeAlD
Tretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.000191	0.00625	CbGpPWpGaD
Tretinoin—CRABP2—spinal cord—germ cell cancer	0.000189	0.0049	CbGeAlD
Tretinoin—CYP3A4—urine—germ cell cancer	0.000189	0.00489	CbGeAlD
Tretinoin—CRABP1—endocrine gland—germ cell cancer	0.000188	0.00488	CbGeAlD
Tretinoin—CYP4A11—endocrine gland—germ cell cancer	0.000188	0.00488	CbGeAlD
Tretinoin—RARG—skin of body—germ cell cancer	0.000188	0.00487	CbGeAlD
Tretinoin—ALDH1A1—gonad—germ cell cancer	0.000188	0.00486	CbGeAlD
Tretinoin—RARG—decidua—germ cell cancer	0.000187	0.00483	CbGeAlD
Tretinoin—ALDH1A1—uterus—germ cell cancer	0.000186	0.00483	CbGeAlD
Tretinoin—ALDH1A2—testis—germ cell cancer	0.000186	0.00482	CbGeAlD
Tretinoin—CRABP1—head—germ cell cancer	0.000186	0.00481	CbGeAlD
Tretinoin—RXRG—medulla oblongata—germ cell cancer	0.000185	0.0048	CbGeAlD
Tretinoin—RARA—telencephalon—germ cell cancer	0.000185	0.00479	CbGeAlD
Tretinoin—ALDH1A1—pituitary gland—germ cell cancer	0.000183	0.00474	CbGeAlD
Tretinoin—CRABP2—female gonad—germ cell cancer	0.000183	0.00474	CbGeAlD
Tretinoin—RXRA—female gonad—germ cell cancer	0.000182	0.00472	CbGeAlD
Tretinoin—RARRES1—brain—germ cell cancer	0.000182	0.00471	CbGeAlD
Tretinoin—CRABP1—testis—germ cell cancer	0.00018	0.00465	CbGeAlD
Tretinoin—ALDH1A1—medulla oblongata—germ cell cancer	0.000177	0.00458	CbGeAlD
Tretinoin—RARRES1—lymph node—germ cell cancer	0.000176	0.00455	CbGeAlD
Tretinoin—RARB—adrenal gland—germ cell cancer	0.000176	0.00455	CbGeAlD
Tretinoin—RARA—decidua—germ cell cancer	0.000175	0.00454	CbGeAlD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—KLF4—germ cell cancer	0.000172	0.00562	CbGpPWpGaD
Tretinoin—ALDH1A2—cerebellum—germ cell cancer	0.000172	0.00445	CbGeAlD
Tretinoin—RXRG—adrenal gland—germ cell cancer	0.000172	0.00444	CbGeAlD
Tretinoin—CRABP2—endocrine gland—germ cell cancer	0.00017	0.00441	CbGeAlD
Tretinoin—RXRA—endocrine gland—germ cell cancer	0.000169	0.00439	CbGeAlD
Tretinoin—RXRG—midbrain—germ cell cancer	0.000169	0.00439	CbGeAlD
Tretinoin—CRABP2—head—germ cell cancer	0.000168	0.00435	CbGeAlD
Tretinoin—RXRA—head—germ cell cancer	0.000167	0.00433	CbGeAlD
Tretinoin—CRABP1—cerebellum—germ cell cancer	0.000166	0.00429	CbGeAlD
Tretinoin—RXRG—spinal cord—germ cell cancer	0.000165	0.00428	CbGeAlD
Tretinoin—RARB—female gonad—germ cell cancer	0.000164	0.00424	CbGeAlD
Tretinoin—ALDH1A1—adrenal gland—germ cell cancer	0.000164	0.00424	CbGeAlD
Tretinoin—RARG—uterus—germ cell cancer	0.000163	0.00423	CbGeAlD
Tretinoin—CRABP2—testis—germ cell cancer	0.000162	0.0042	CbGeAlD
Tretinoin—ALDH1A1—midbrain—germ cell cancer	0.000161	0.00418	CbGeAlD
Tretinoin—RXRB—adrenal gland—germ cell cancer	0.000161	0.00418	CbGeAlD
Tretinoin—CYP2B6—Metapathway biotransformation—NAT9—germ cell cancer	0.00016	0.00524	CbGpPWpGaD
Tretinoin—ALDH1A1—bone marrow—germ cell cancer	0.000158	0.0041	CbGeAlD
Tretinoin—ALDH1A1—spinal cord—germ cell cancer	0.000158	0.00408	CbGeAlD
Tretinoin—NR0B1—brain—germ cell cancer	0.000157	0.00406	CbGeAlD
Tretinoin—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000157	0.00512	CbGpPWpGaD
Tretinoin—RARA—gonad—germ cell cancer	0.000154	0.004	CbGeAlD
Tretinoin—RARA—uterus—germ cell cancer	0.000153	0.00398	CbGeAlD
Tretinoin—ALDH1A1—female gonad—germ cell cancer	0.000153	0.00395	CbGeAlD
Tretinoin—RARB—endocrine gland—germ cell cancer	0.000152	0.00394	CbGeAlD
Tretinoin—RARA—pituitary gland—germ cell cancer	0.000151	0.0039	CbGeAlD
Tretinoin—RXRB—female gonad—germ cell cancer	0.00015	0.0039	CbGeAlD
Tretinoin—RARB—head—germ cell cancer	0.00015	0.00389	CbGeAlD
Tretinoin—CRABP2—cerebellum—germ cell cancer	0.00015	0.00388	CbGeAlD
Tretinoin—RXRG—endocrine gland—germ cell cancer	0.000149	0.00385	CbGeAlD
Tretinoin—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000148	0.00484	CbGpPWpGaD
Tretinoin—RXRG—head—germ cell cancer	0.000147	0.0038	CbGeAlD
Tretinoin—RARG—adrenal gland—germ cell cancer	0.000143	0.00371	CbGeAlD
Tretinoin—RXRG—testis—germ cell cancer	0.000142	0.00368	CbGeAlD
Tretinoin—ALDH1A1—endocrine gland—germ cell cancer	0.000142	0.00367	CbGeAlD
Tretinoin—RARG—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00014	0.00459	CbGpPWpGaD
Tretinoin—ALDH1A1—head—germ cell cancer	0.00014	0.00363	CbGeAlD
Tretinoin—RXRB—endocrine gland—germ cell cancer	0.00014	0.00362	CbGeAlD
Tretinoin—ALDH1A2—brain—germ cell cancer	0.00014	0.00362	CbGeAlD
Tretinoin—RXRB—head—germ cell cancer	0.000138	0.00358	CbGeAlD
Tretinoin—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000136	0.00443	CbGpPWpGaD
Tretinoin—ALDH1A1—testis—germ cell cancer	0.000135	0.0035	CbGeAlD
Tretinoin—ALDH1A2—lymph node—germ cell cancer	0.000135	0.00349	CbGeAlD
Tretinoin—CRABP1—brain—germ cell cancer	0.000135	0.00349	CbGeAlD
Tretinoin—RARA—adrenal gland—germ cell cancer	0.000135	0.00349	CbGeAlD
Tretinoin—RARB—cerebellum—germ cell cancer	0.000134	0.00347	CbGeAlD
Tretinoin—RARG—female gonad—germ cell cancer	0.000134	0.00346	CbGeAlD
Tretinoin—RXRB—testis—germ cell cancer	0.000133	0.00346	CbGeAlD
Tretinoin—RARA—bone marrow—germ cell cancer	0.00013	0.00337	CbGeAlD
Tretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.000128	0.0042	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000128	0.00419	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000126	0.00411	CbGpPWpGaD
Tretinoin—RARA—female gonad—germ cell cancer	0.000126	0.00325	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—germ cell cancer	0.000125	0.00324	CbGeAlD
Tretinoin—CYP2C18—endocrine gland—germ cell cancer	0.000125	0.00323	CbGeAlD
Tretinoin—RXRB—cerebellum—germ cell cancer	0.000123	0.00319	CbGeAlD
Tretinoin—RARG—head—germ cell cancer	0.000123	0.00318	CbGeAlD
Tretinoin—CRABP2—brain—germ cell cancer	0.000122	0.00315	CbGeAlD
Tretinoin—RXRA—brain—germ cell cancer	0.000121	0.00314	CbGeAlD
Tretinoin—RARA—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000121	0.00394	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000121	0.00394	CbGpPWpGaD
Tretinoin—CYP3A7—endocrine gland—germ cell cancer	0.000119	0.00307	CbGeAlD
Tretinoin—RARG—testis—germ cell cancer	0.000118	0.00307	CbGeAlD
Tretinoin—CYP4A11—NRF2 pathway—SLC2A3—germ cell cancer	0.000117	0.00383	CbGpPWpGaD
Tretinoin—RARA—endocrine gland—germ cell cancer	0.000117	0.00302	CbGeAlD
Tretinoin—RARA—head—germ cell cancer	0.000115	0.00299	CbGeAlD
Tretinoin—RARA—testis—germ cell cancer	0.000111	0.00288	CbGeAlD
Tretinoin—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.00011	0.00361	CbGpPWpGaD
Tretinoin—RARG—cerebellum—germ cell cancer	0.000109	0.00283	CbGeAlD
Tretinoin—RARB—brain—germ cell cancer	0.000109	0.00282	CbGeAlD
Tretinoin—RXRG—brain—germ cell cancer	0.000106	0.00276	CbGeAlD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000106	0.00345	CbGpPWpGaD
Tretinoin—RARB—lymph node—germ cell cancer	0.000105	0.00273	CbGeAlD
Tretinoin—RARA—cerebellum—germ cell cancer	0.000103	0.00266	CbGeAlD
Tretinoin—ALDH1A1—brain—germ cell cancer	0.000101	0.00263	CbGeAlD
Tretinoin—RXRB—brain—germ cell cancer	0.0001	0.00259	CbGeAlD
Tretinoin—ALDH1A1—lymph node—germ cell cancer	9.81e-05	0.00254	CbGeAlD
Tretinoin—RXRA—Circadian Clock—AVP—germ cell cancer	9.35e-05	0.00306	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—SLC2A3—germ cell cancer	9.28e-05	0.00303	CbGpPWpGaD
Tretinoin—RARG—brain—germ cell cancer	8.88e-05	0.0023	CbGeAlD
Tretinoin—NR0B1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	8.81e-05	0.00288	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.67e-05	0.00283	CbGpPWpGaD
Tretinoin—RARG—lymph node—germ cell cancer	8.58e-05	0.00222	CbGeAlD
Tretinoin—RARA—brain—germ cell cancer	8.35e-05	0.00216	CbGeAlD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.29e-05	0.00271	CbGpPWpGaD
Tretinoin—CYP4A11—PPAR Alpha Pathway—MYC—germ cell cancer	8.25e-05	0.0027	CbGpPWpGaD
Tretinoin—RARA—lymph node—germ cell cancer	8.07e-05	0.00209	CbGeAlD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	7.95e-05	0.0026	CbGpPWpGaD
Tretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	7.41e-05	0.00242	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	7.28e-05	0.00238	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—DNMT3L—germ cell cancer	7.27e-05	0.00238	CbGpPWpGaD
Tretinoin—CYP2A6—cerebellum—germ cell cancer	7.26e-05	0.00188	CbGeAlD
Tretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	6.76e-05	0.00221	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—NR0B1—germ cell cancer	6.75e-05	0.00221	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—RARS—germ cell cancer	6.75e-05	0.00221	CbGpPWpGaD
Tretinoin—RXRA—PPAR Alpha Pathway—MYC—germ cell cancer	6.54e-05	0.00214	CbGpPWpGaD
Tretinoin—CYP1A1—skin of body—germ cell cancer	6.46e-05	0.00167	CbGeAlD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	6.36e-05	0.00208	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	6.31e-05	0.00206	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TDGF1—germ cell cancer	6.29e-05	0.00206	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NR0B1—germ cell cancer	6.29e-05	0.00206	CbGpPWpGaD
Tretinoin—CYP2B6—skin of body—germ cell cancer	6.28e-05	0.00163	CbGeAlD
Tretinoin—CYP2A6—NRF2 pathway—SLC2A3—germ cell cancer	6.23e-05	0.00204	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—NR0B1—germ cell cancer	6.18e-05	0.00202	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NR0B1—germ cell cancer	6.06e-05	0.00198	CbGpPWpGaD
Tretinoin—CYP2C8—pituitary gland—germ cell cancer	5.97e-05	0.00155	CbGeAlD
Tretinoin—CYP2A6—brain—germ cell cancer	5.9e-05	0.00153	CbGeAlD
Tretinoin—RARG—Gene Expression—DNMT3L—germ cell cancer	5.86e-05	0.00191	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NR0B1—germ cell cancer	5.81e-05	0.0019	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NR0B1—germ cell cancer	5.81e-05	0.0019	CbGpPWpGaD
Tretinoin—CYP1A1—uterus—germ cell cancer	5.61e-05	0.00145	CbGeAlD
Tretinoin—CYP2B6—gonad—germ cell cancer	5.49e-05	0.00142	CbGeAlD
Tretinoin—RARG—Gene Expression—RARS—germ cell cancer	5.44e-05	0.00178	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—DNMT3L—germ cell cancer	5.36e-05	0.00175	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—SALL4—germ cell cancer	5.35e-05	0.00175	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—DNMT3L—germ cell cancer	5.25e-05	0.00172	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—NANOG—germ cell cancer	5.13e-05	0.00168	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—DNMT3L—germ cell cancer	5.04e-05	0.00165	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—DNMT3L—germ cell cancer	5.04e-05	0.00165	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—RARS—germ cell cancer	4.98e-05	0.00163	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—POU5F1—germ cell cancer	4.94e-05	0.00161	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—RARS—germ cell cancer	4.88e-05	0.0016	CbGpPWpGaD
Tretinoin—CYP2B6—adrenal gland—germ cell cancer	4.79e-05	0.00124	CbGeAlD
Tretinoin—Erythema multiforme—Etoposide—germ cell cancer	4.77e-05	0.000822	CcSEcCtD
Tretinoin—Paraesthesia—Bleomycin—germ cell cancer	4.77e-05	0.000822	CcSEcCtD
Tretinoin—Dyspnoea—Bleomycin—germ cell cancer	4.73e-05	0.000816	CcSEcCtD
Tretinoin—Chest pain—Ifosfamide—germ cell cancer	4.73e-05	0.000816	CcSEcCtD
Tretinoin—Arthralgia—Ifosfamide—germ cell cancer	4.73e-05	0.000816	CcSEcCtD
Tretinoin—Myalgia—Ifosfamide—germ cell cancer	4.73e-05	0.000816	CcSEcCtD
Tretinoin—Renal failure acute—Methotrexate—germ cell cancer	4.73e-05	0.000816	CcSEcCtD
Tretinoin—Flatulence—Cisplatin—germ cell cancer	4.72e-05	0.000814	CcSEcCtD
Tretinoin—Anorexia—Dactinomycin—germ cell cancer	4.72e-05	0.000814	CcSEcCtD
Tretinoin—Eye disorder—Etoposide—germ cell cancer	4.71e-05	0.000813	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	4.7e-05	0.000811	CcSEcCtD
Tretinoin—RXRB—Gene Expression—RARS—germ cell cancer	4.68e-05	0.00153	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—RARS—germ cell cancer	4.68e-05	0.00153	CbGpPWpGaD
Tretinoin—Flushing—Etoposide—germ cell cancer	4.68e-05	0.000807	CcSEcCtD
Tretinoin—Discomfort—Ifosfamide—germ cell cancer	4.68e-05	0.000806	CcSEcCtD
Tretinoin—Hypersensitivity—Vinblastine—germ cell cancer	4.63e-05	0.000799	CcSEcCtD
Tretinoin—Dermatitis exfoliative—Methotrexate—germ cell cancer	4.63e-05	0.000798	CcSEcCtD
Tretinoin—CYP2C8—endocrine gland—germ cell cancer	4.63e-05	0.0012	CbGeAlD
Tretinoin—Decreased appetite—Bleomycin—germ cell cancer	4.62e-05	0.000796	CcSEcCtD
Tretinoin—Visual disturbance—Methotrexate—germ cell cancer	4.61e-05	0.000795	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—SLC2A3—germ cell cancer	4.6e-05	0.0015	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SLC2A3—germ cell cancer	4.6e-05	0.0015	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SLC2A3—germ cell cancer	4.6e-05	0.0015	CbGpPWpGaD
Tretinoin—CYP1A1—female gonad—germ cell cancer	4.59e-05	0.00119	CbGeAlD
Tretinoin—Angiopathy—Etoposide—germ cell cancer	4.58e-05	0.000789	CcSEcCtD
Tretinoin—Confusional state—Ifosfamide—germ cell cancer	4.57e-05	0.000789	CcSEcCtD
Tretinoin—RXRA—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.55e-05	0.00149	CbGpPWpGaD
Tretinoin—Pain—Bleomycin—germ cell cancer	4.54e-05	0.000783	CcSEcCtD
Tretinoin—Oedema—Ifosfamide—germ cell cancer	4.54e-05	0.000782	CcSEcCtD
Tretinoin—Anaphylactic shock—Ifosfamide—germ cell cancer	4.54e-05	0.000782	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—SLC22A3—germ cell cancer	4.53e-05	0.00148	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SLC22A3—germ cell cancer	4.53e-05	0.00148	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SLC22A3—germ cell cancer	4.53e-05	0.00148	CbGpPWpGaD
Tretinoin—Chills—Etoposide—germ cell cancer	4.53e-05	0.00078	CcSEcCtD
Tretinoin—Vision blurred—Cisplatin—germ cell cancer	4.52e-05	0.000779	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	4.51e-05	0.000778	CcSEcCtD
Tretinoin—Asthenia—Vinblastine—germ cell cancer	4.51e-05	0.000778	CcSEcCtD
Tretinoin—Infection—Ifosfamide—germ cell cancer	4.51e-05	0.000777	CcSEcCtD
Tretinoin—Tremor—Cisplatin—germ cell cancer	4.49e-05	0.000774	CcSEcCtD
Tretinoin—CYP3A5—female gonad—germ cell cancer	4.49e-05	0.00116	CbGeAlD
Tretinoin—Alopecia—Etoposide—germ cell cancer	4.46e-05	0.000769	CcSEcCtD
Tretinoin—Lethargy—Methotrexate—germ cell cancer	4.46e-05	0.000768	CcSEcCtD
Tretinoin—Cerebrovascular accident—Methotrexate—germ cell cancer	4.46e-05	0.000768	CcSEcCtD
Tretinoin—Nervous system disorder—Ifosfamide—germ cell cancer	4.45e-05	0.000767	CcSEcCtD
Tretinoin—Ill-defined disorder—Cisplatin—germ cell cancer	4.45e-05	0.000767	CcSEcCtD
Tretinoin—Thrombocytopenia—Ifosfamide—germ cell cancer	4.44e-05	0.000766	CcSEcCtD
Tretinoin—Anaemia—Cisplatin—germ cell cancer	4.43e-05	0.000764	CcSEcCtD
Tretinoin—CYP2C8—testis—germ cell cancer	4.41e-05	0.00114	CbGeAlD
Tretinoin—Skin disorder—Ifosfamide—germ cell cancer	4.41e-05	0.00076	CcSEcCtD
Tretinoin—Hyperhidrosis—Ifosfamide—germ cell cancer	4.39e-05	0.000756	CcSEcCtD
Tretinoin—Feeling abnormal—Bleomycin—germ cell cancer	4.37e-05	0.000754	CcSEcCtD
Tretinoin—Osteoarthritis—Methotrexate—germ cell cancer	4.37e-05	0.000753	CcSEcCtD
Tretinoin—Anorexia—Ifosfamide—germ cell cancer	4.32e-05	0.000746	CcSEcCtD
Tretinoin—Malaise—Cisplatin—germ cell cancer	4.32e-05	0.000745	CcSEcCtD
Tretinoin—Decreased appetite—Dactinomycin—germ cell cancer	4.3e-05	0.000742	CcSEcCtD
Tretinoin—Diarrhoea—Vinblastine—germ cell cancer	4.3e-05	0.000742	CcSEcCtD
Tretinoin—CYP1A1—endocrine gland—germ cell cancer	4.27e-05	0.00111	CbGeAlD
Tretinoin—Fatigue—Dactinomycin—germ cell cancer	4.27e-05	0.000736	CcSEcCtD
Tretinoin—Back pain—Etoposide—germ cell cancer	4.25e-05	0.000732	CcSEcCtD
Tretinoin—Hypotension—Ifosfamide—germ cell cancer	4.24e-05	0.000731	CcSEcCtD
Tretinoin—Pain—Dactinomycin—germ cell cancer	4.23e-05	0.00073	CcSEcCtD
Tretinoin—Urticaria—Bleomycin—germ cell cancer	4.22e-05	0.000727	CcSEcCtD
Tretinoin—CYP1A1—head—germ cell cancer	4.22e-05	0.00109	CbGeAlD
Tretinoin—Body temperature increased—Bleomycin—germ cell cancer	4.2e-05	0.000724	CcSEcCtD
Tretinoin—CYP3A5—endocrine gland—germ cell cancer	4.18e-05	0.00108	CbGeAlD
Tretinoin—Irritability—Methotrexate—germ cell cancer	4.17e-05	0.000719	CcSEcCtD
Tretinoin—Dizziness—Vinblastine—germ cell cancer	4.16e-05	0.000717	CcSEcCtD
Tretinoin—Convulsion—Cisplatin—germ cell cancer	4.15e-05	0.000716	CcSEcCtD
Tretinoin—CYP2B6—endocrine gland—germ cell cancer	4.15e-05	0.00107	CbGeAlD
Tretinoin—Mood swings—Methotrexate—germ cell cancer	4.14e-05	0.000713	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	4.13e-05	0.000713	CcSEcCtD
Tretinoin—CYP2C9—endocrine gland—germ cell cancer	4.11e-05	0.00106	CbGeAlD
Tretinoin—CYP2B6—head—germ cell cancer	4.1e-05	0.00106	CbGeAlD
Tretinoin—Myalgia—Cisplatin—germ cell cancer	4.08e-05	0.000704	CcSEcCtD
Tretinoin—Feeling abnormal—Dactinomycin—germ cell cancer	4.08e-05	0.000704	CcSEcCtD
Tretinoin—Paraesthesia—Ifosfamide—germ cell cancer	4.07e-05	0.000703	CcSEcCtD
Tretinoin—Ill-defined disorder—Etoposide—germ cell cancer	4.07e-05	0.000702	CcSEcCtD
Tretinoin—Anxiety—Cisplatin—germ cell cancer	4.07e-05	0.000701	CcSEcCtD
Tretinoin—Anaemia—Etoposide—germ cell cancer	4.06e-05	0.0007	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	4.05e-05	0.000699	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dactinomycin—germ cell cancer	4.05e-05	0.000698	CcSEcCtD
Tretinoin—Dyspnoea—Ifosfamide—germ cell cancer	4.05e-05	0.000698	CcSEcCtD
Tretinoin—Somnolence—Ifosfamide—germ cell cancer	4.03e-05	0.000696	CcSEcCtD
Tretinoin—Discomfort—Cisplatin—germ cell cancer	4.03e-05	0.000695	CcSEcCtD
Tretinoin—Vomiting—Vinblastine—germ cell cancer	4e-05	0.000689	CcSEcCtD
Tretinoin—Malaise—Etoposide—germ cell cancer	3.96e-05	0.000683	CcSEcCtD
Tretinoin—CYP2B6—testis—germ cell cancer	3.96e-05	0.00102	CbGeAlD
Tretinoin—Decreased appetite—Ifosfamide—germ cell cancer	3.94e-05	0.00068	CcSEcCtD
Tretinoin—Headache—Vinblastine—germ cell cancer	3.94e-05	0.000679	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	3.93e-05	0.000678	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	3.92e-05	0.000675	CcSEcCtD
Tretinoin—Abdominal pain—Dactinomycin—germ cell cancer	3.91e-05	0.000675	CcSEcCtD
Tretinoin—Body temperature increased—Dactinomycin—germ cell cancer	3.91e-05	0.000675	CcSEcCtD
Tretinoin—Fatigue—Ifosfamide—germ cell cancer	3.91e-05	0.000675	CcSEcCtD
Tretinoin—Anaphylactic shock—Cisplatin—germ cell cancer	3.91e-05	0.000674	CcSEcCtD
Tretinoin—Oedema—Cisplatin—germ cell cancer	3.91e-05	0.000674	CcSEcCtD
Tretinoin—Hypersensitivity—Bleomycin—germ cell cancer	3.91e-05	0.000674	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—KLF4—germ cell cancer	3.89e-05	0.00127	CbGpPWpGaD
Tretinoin—Infection—Cisplatin—germ cell cancer	3.89e-05	0.00067	CcSEcCtD
Tretinoin—Pain—Ifosfamide—germ cell cancer	3.88e-05	0.000669	CcSEcCtD
Tretinoin—Constipation—Ifosfamide—germ cell cancer	3.88e-05	0.000669	CcSEcCtD
Tretinoin—Loss of consciousness—Etoposide—germ cell cancer	3.86e-05	0.000665	CcSEcCtD
Tretinoin—Nervous system disorder—Cisplatin—germ cell cancer	3.84e-05	0.000661	CcSEcCtD
Tretinoin—Cough—Etoposide—germ cell cancer	3.83e-05	0.000661	CcSEcCtD
Tretinoin—Thrombocytopenia—Cisplatin—germ cell cancer	3.83e-05	0.00066	CcSEcCtD
Tretinoin—Tachycardia—Cisplatin—germ cell cancer	3.82e-05	0.000658	CcSEcCtD
Tretinoin—Asthenia—Bleomycin—germ cell cancer	3.81e-05	0.000657	CcSEcCtD
Tretinoin—Convulsion—Etoposide—germ cell cancer	3.8e-05	0.000656	CcSEcCtD
Tretinoin—Skin disorder—Cisplatin—germ cell cancer	3.8e-05	0.000655	CcSEcCtD
Tretinoin—Hypertension—Etoposide—germ cell cancer	3.79e-05	0.000654	CcSEcCtD
Tretinoin—Hyperhidrosis—Cisplatin—germ cell cancer	3.78e-05	0.000652	CcSEcCtD
Tretinoin—Asthma—Methotrexate—germ cell cancer	3.77e-05	0.000651	CcSEcCtD
Tretinoin—Pruritus—Bleomycin—germ cell cancer	3.76e-05	0.000648	CcSEcCtD
Tretinoin—Feeling abnormal—Ifosfamide—germ cell cancer	3.74e-05	0.000645	CcSEcCtD
Tretinoin—Chest pain—Etoposide—germ cell cancer	3.74e-05	0.000645	CcSEcCtD
Tretinoin—Nausea—Vinblastine—germ cell cancer	3.73e-05	0.000644	CcSEcCtD
Tretinoin—Anorexia—Cisplatin—germ cell cancer	3.73e-05	0.000643	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	3.71e-05	0.00064	CcSEcCtD
Tretinoin—Gastrointestinal pain—Ifosfamide—germ cell cancer	3.71e-05	0.00064	CcSEcCtD
Tretinoin—Pancreatitis—Methotrexate—germ cell cancer	3.7e-05	0.000638	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—CRABP1—germ cell cancer	3.69e-05	0.00121	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CRABP1—germ cell cancer	3.69e-05	0.00121	CbGpPWpGaD
Tretinoin—Discomfort—Etoposide—germ cell cancer	3.69e-05	0.000637	CcSEcCtD
Tretinoin—Hypotension—Cisplatin—germ cell cancer	3.66e-05	0.00063	CcSEcCtD
Tretinoin—Hypersensitivity—Dactinomycin—germ cell cancer	3.65e-05	0.000629	CcSEcCtD
Tretinoin—Abdominal discomfort—Methotrexate—germ cell cancer	3.62e-05	0.000624	CcSEcCtD
Tretinoin—Confusional state—Etoposide—germ cell cancer	3.61e-05	0.000623	CcSEcCtD
Tretinoin—Urticaria—Ifosfamide—germ cell cancer	3.6e-05	0.000622	CcSEcCtD
Tretinoin—Body temperature increased—Ifosfamide—germ cell cancer	3.59e-05	0.000618	CcSEcCtD
Tretinoin—Abdominal pain—Ifosfamide—germ cell cancer	3.59e-05	0.000618	CcSEcCtD
Tretinoin—Anaphylactic shock—Etoposide—germ cell cancer	3.58e-05	0.000618	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	3.56e-05	0.000615	CcSEcCtD
Tretinoin—Infection—Etoposide—germ cell cancer	3.56e-05	0.000614	CcSEcCtD
Tretinoin—Asthenia—Dactinomycin—germ cell cancer	3.55e-05	0.000613	CcSEcCtD
Tretinoin—Neutropenia—Methotrexate—germ cell cancer	3.53e-05	0.000609	CcSEcCtD
Tretinoin—Dysuria—Methotrexate—germ cell cancer	3.53e-05	0.000609	CcSEcCtD
Tretinoin—Paraesthesia—Cisplatin—germ cell cancer	3.51e-05	0.000606	CcSEcCtD
Tretinoin—Thrombocytopenia—Etoposide—germ cell cancer	3.51e-05	0.000605	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Methotrexate—germ cell cancer	3.51e-05	0.000605	CcSEcCtD
Tretinoin—Tachycardia—Etoposide—germ cell cancer	3.5e-05	0.000603	CcSEcCtD
Tretinoin—Dyspnoea—Cisplatin—germ cell cancer	3.49e-05	0.000601	CcSEcCtD
Tretinoin—Skin disorder—Etoposide—germ cell cancer	3.48e-05	0.0006	CcSEcCtD
Tretinoin—Hyperhidrosis—Etoposide—germ cell cancer	3.46e-05	0.000597	CcSEcCtD
Tretinoin—Photosensitivity reaction—Methotrexate—germ cell cancer	3.45e-05	0.000594	CcSEcCtD
Tretinoin—Anorexia—Etoposide—germ cell cancer	3.42e-05	0.000589	CcSEcCtD
Tretinoin—Decreased appetite—Cisplatin—germ cell cancer	3.4e-05	0.000586	CcSEcCtD
Tretinoin—Diarrhoea—Dactinomycin—germ cell cancer	3.39e-05	0.000584	CcSEcCtD
Tretinoin—Pneumonia—Methotrexate—germ cell cancer	3.39e-05	0.000584	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Cisplatin—germ cell cancer	3.38e-05	0.000582	CcSEcCtD
Tretinoin—Vomiting—Bleomycin—germ cell cancer	3.38e-05	0.000582	CcSEcCtD
Tretinoin—Infestation NOS—Methotrexate—germ cell cancer	3.37e-05	0.00058	CcSEcCtD
Tretinoin—Infestation—Methotrexate—germ cell cancer	3.37e-05	0.00058	CcSEcCtD
Tretinoin—Drowsiness—Methotrexate—germ cell cancer	3.37e-05	0.00058	CcSEcCtD
Tretinoin—Depression—Methotrexate—germ cell cancer	3.36e-05	0.000579	CcSEcCtD
Tretinoin—Hypotension—Etoposide—germ cell cancer	3.35e-05	0.000577	CcSEcCtD
Tretinoin—Rash—Bleomycin—germ cell cancer	3.35e-05	0.000577	CcSEcCtD
Tretinoin—Pain—Cisplatin—germ cell cancer	3.34e-05	0.000577	CcSEcCtD
Tretinoin—Dermatitis—Bleomycin—germ cell cancer	3.34e-05	0.000577	CcSEcCtD
Tretinoin—Hypersensitivity—Ifosfamide—germ cell cancer	3.34e-05	0.000576	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	3.34e-05	0.000575	CcSEcCtD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	3.31e-05	0.00108	CbGpPWpGaD
Tretinoin—CYP2C8—brain—germ cell cancer	3.31e-05	0.000857	CbGeAlD
Tretinoin—Renal failure—Methotrexate—germ cell cancer	3.31e-05	0.00057	CcSEcCtD
Tretinoin—Stomatitis—Methotrexate—germ cell cancer	3.28e-05	0.000566	CcSEcCtD
Tretinoin—Conjunctivitis—Methotrexate—germ cell cancer	3.27e-05	0.000564	CcSEcCtD
Tretinoin—Asthenia—Ifosfamide—germ cell cancer	3.26e-05	0.000561	CcSEcCtD
Tretinoin—Sweating—Methotrexate—germ cell cancer	3.23e-05	0.000556	CcSEcCtD
Tretinoin—Feeling abnormal—Cisplatin—germ cell cancer	3.22e-05	0.000556	CcSEcCtD
Tretinoin—Paraesthesia—Etoposide—germ cell cancer	3.22e-05	0.000555	CcSEcCtD
Tretinoin—Pruritus—Ifosfamide—germ cell cancer	3.21e-05	0.000554	CcSEcCtD
Tretinoin—Haematuria—Methotrexate—germ cell cancer	3.21e-05	0.000553	CcSEcCtD
Tretinoin—Dyspnoea—Etoposide—germ cell cancer	3.19e-05	0.000551	CcSEcCtD
Tretinoin—Somnolence—Etoposide—germ cell cancer	3.19e-05	0.000549	CcSEcCtD
Tretinoin—Epistaxis—Methotrexate—germ cell cancer	3.17e-05	0.000547	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.17e-05	0.00103	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	3.15e-05	0.00103	CbGpPWpGaD
Tretinoin—Nausea—Bleomycin—germ cell cancer	3.15e-05	0.000544	CcSEcCtD
Tretinoin—Vomiting—Dactinomycin—germ cell cancer	3.15e-05	0.000543	CcSEcCtD
Tretinoin—Agranulocytosis—Methotrexate—germ cell cancer	3.14e-05	0.000542	CcSEcCtD
Tretinoin—CYP3A4—endocrine gland—germ cell cancer	3.13e-05	0.000812	CbGeAlD
Tretinoin—Rash—Dactinomycin—germ cell cancer	3.12e-05	0.000538	CcSEcCtD
Tretinoin—Decreased appetite—Etoposide—germ cell cancer	3.12e-05	0.000537	CcSEcCtD
Tretinoin—Diarrhoea—Ifosfamide—germ cell cancer	3.1e-05	0.000535	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Etoposide—germ cell cancer	3.09e-05	0.000533	CcSEcCtD
Tretinoin—Body temperature increased—Cisplatin—germ cell cancer	3.09e-05	0.000533	CcSEcCtD
Tretinoin—Fatigue—Etoposide—germ cell cancer	3.09e-05	0.000533	CcSEcCtD
Tretinoin—Constipation—Etoposide—germ cell cancer	3.06e-05	0.000528	CcSEcCtD
Tretinoin—Pain—Etoposide—germ cell cancer	3.06e-05	0.000528	CcSEcCtD
Tretinoin—CYP1A1—brain—germ cell cancer	3.05e-05	0.000791	CbGeAlD
Tretinoin—Haemoglobin—Methotrexate—germ cell cancer	3.04e-05	0.000524	CcSEcCtD
Tretinoin—RXRA—Gene Expression—NR0B1—germ cell cancer	3.03e-05	0.00099	CbGpPWpGaD
Tretinoin—Haemorrhage—Methotrexate—germ cell cancer	3.02e-05	0.000521	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—germ cell cancer	3.02e-05	0.000521	CcSEcCtD
Tretinoin—Dizziness—Ifosfamide—germ cell cancer	3e-05	0.000517	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—germ cell cancer	3e-05	0.000517	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—germ cell cancer	2.98e-05	0.000514	CcSEcCtD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—germ cell cancer	2.98e-05	0.000974	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.97e-05	0.000972	CbGpPWpGaD
Tretinoin—CYP2B6—brain—germ cell cancer	2.97e-05	0.000769	CbGeAlD
Tretinoin—Urethral disorder—Methotrexate—germ cell cancer	2.96e-05	0.000511	CcSEcCtD
Tretinoin—Feeling abnormal—Etoposide—germ cell cancer	2.95e-05	0.000509	CcSEcCtD
Tretinoin—CYP1A1—lymph node—germ cell cancer	2.95e-05	0.000765	CbGeAlD
Tretinoin—Nausea—Dactinomycin—germ cell cancer	2.94e-05	0.000507	CcSEcCtD
Tretinoin—Gastrointestinal pain—Etoposide—germ cell cancer	2.93e-05	0.000505	CcSEcCtD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.93e-05	0.000957	CbGpPWpGaD
Tretinoin—Visual impairment—Methotrexate—germ cell cancer	2.91e-05	0.000502	CcSEcCtD
Tretinoin—Vomiting—Ifosfamide—germ cell cancer	2.88e-05	0.000497	CcSEcCtD
Tretinoin—Hypersensitivity—Cisplatin—germ cell cancer	2.88e-05	0.000497	CcSEcCtD
Tretinoin—Rash—Ifosfamide—germ cell cancer	2.86e-05	0.000493	CcSEcCtD
Tretinoin—Dermatitis—Ifosfamide—germ cell cancer	2.86e-05	0.000493	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—germ cell cancer	2.86e-05	0.000493	CcSEcCtD
Tretinoin—Urticaria—Etoposide—germ cell cancer	2.85e-05	0.000491	CcSEcCtD
Tretinoin—Body temperature increased—Etoposide—germ cell cancer	2.83e-05	0.000488	CcSEcCtD
Tretinoin—Abdominal pain—Etoposide—germ cell cancer	2.83e-05	0.000488	CcSEcCtD
Tretinoin—Eye disorder—Methotrexate—germ cell cancer	2.82e-05	0.000487	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—germ cell cancer	2.82e-05	0.000486	CcSEcCtD
Tretinoin—Asthenia—Cisplatin—germ cell cancer	2.81e-05	0.000484	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—germ cell cancer	2.74e-05	0.000473	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—SOX2—germ cell cancer	2.74e-05	0.000896	CbGpPWpGaD
Tretinoin—Chills—Methotrexate—germ cell cancer	2.71e-05	0.000467	CcSEcCtD
Tretinoin—Nausea—Ifosfamide—germ cell cancer	2.7e-05	0.000465	CcSEcCtD
Tretinoin—Diarrhoea—Cisplatin—germ cell cancer	2.68e-05	0.000461	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—germ cell cancer	2.67e-05	0.00046	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.66e-05	0.000868	CbGpPWpGaD
Tretinoin—Mental disorder—Methotrexate—germ cell cancer	2.65e-05	0.000456	CcSEcCtD
Tretinoin—Hypersensitivity—Etoposide—germ cell cancer	2.64e-05	0.000455	CcSEcCtD
Tretinoin—Malnutrition—Methotrexate—germ cell cancer	2.63e-05	0.000454	CcSEcCtD
Tretinoin—Erythema—Methotrexate—germ cell cancer	2.63e-05	0.000454	CcSEcCtD
Tretinoin—RXRA—Gene Expression—DNMT3L—germ cell cancer	2.62e-05	0.000858	CbGpPWpGaD
Tretinoin—Asthenia—Etoposide—germ cell cancer	2.57e-05	0.000443	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.55e-05	0.000832	CbGpPWpGaD
Tretinoin—Back pain—Methotrexate—germ cell cancer	2.54e-05	0.000439	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—H2AFZ—germ cell cancer	2.54e-05	0.000831	CbGpPWpGaD
Tretinoin—Pruritus—Etoposide—germ cell cancer	2.54e-05	0.000437	CcSEcCtD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.51e-05	0.000821	CbGpPWpGaD
Tretinoin—Vomiting—Cisplatin—germ cell cancer	2.49e-05	0.000429	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—germ cell cancer	2.48e-05	0.000427	CcSEcCtD
Tretinoin—Rash—Cisplatin—germ cell cancer	2.47e-05	0.000425	CcSEcCtD
Tretinoin—Dermatitis—Cisplatin—germ cell cancer	2.46e-05	0.000425	CcSEcCtD
Tretinoin—Diarrhoea—Etoposide—germ cell cancer	2.45e-05	0.000423	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—germ cell cancer	2.44e-05	0.000421	CcSEcCtD
Tretinoin—RXRA—Gene Expression—RARS—germ cell cancer	2.44e-05	0.000798	CbGpPWpGaD
Tretinoin—Anaemia—Methotrexate—germ cell cancer	2.43e-05	0.000419	CcSEcCtD
Tretinoin—Malaise—Methotrexate—germ cell cancer	2.37e-05	0.000409	CcSEcCtD
Tretinoin—Dizziness—Etoposide—germ cell cancer	2.37e-05	0.000409	CcSEcCtD
Tretinoin—Nausea—Cisplatin—germ cell cancer	2.32e-05	0.000401	CcSEcCtD
Tretinoin—Cough—Methotrexate—germ cell cancer	2.3e-05	0.000396	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—germ cell cancer	2.28e-05	0.000393	CcSEcCtD
Tretinoin—Vomiting—Etoposide—germ cell cancer	2.28e-05	0.000393	CcSEcCtD
Tretinoin—Rash—Etoposide—germ cell cancer	2.26e-05	0.00039	CcSEcCtD
Tretinoin—Dermatitis—Etoposide—germ cell cancer	2.26e-05	0.000389	CcSEcCtD
Tretinoin—Headache—Etoposide—germ cell cancer	2.24e-05	0.000387	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—germ cell cancer	2.24e-05	0.000386	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—germ cell cancer	2.24e-05	0.000386	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—germ cell cancer	2.24e-05	0.000386	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	2.22e-05	0.000383	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—germ cell cancer	2.21e-05	0.000381	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.18e-05	0.000713	CbGpPWpGaD
Tretinoin—Confusional state—Methotrexate—germ cell cancer	2.16e-05	0.000373	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—germ cell cancer	2.15e-05	0.00037	CcSEcCtD
Tretinoin—Infection—Methotrexate—germ cell cancer	2.13e-05	0.000368	CcSEcCtD
Tretinoin—Nausea—Etoposide—germ cell cancer	2.13e-05	0.000367	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—germ cell cancer	2.11e-05	0.000363	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—germ cell cancer	2.1e-05	0.000362	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.09e-05	0.000683	CbGpPWpGaD
Tretinoin—Skin disorder—Methotrexate—germ cell cancer	2.08e-05	0.00036	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—germ cell cancer	2.08e-05	0.000358	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.07e-05	0.000678	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—H2AFZ—germ cell cancer	2.05e-05	0.00067	CbGpPWpGaD
Tretinoin—Anorexia—Methotrexate—germ cell cancer	2.05e-05	0.000353	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—germ cell cancer	2.01e-05	0.000346	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	1.96e-05	0.000337	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—germ cell cancer	1.94e-05	0.000335	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—germ cell cancer	1.93e-05	0.000332	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—germ cell cancer	1.91e-05	0.00033	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—germ cell cancer	1.91e-05	0.000329	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—germ cell cancer	1.89e-05	0.000326	CcSEcCtD
Tretinoin—RXRG—Gene Expression—H2AFZ—germ cell cancer	1.87e-05	0.000613	CbGpPWpGaD
Tretinoin—Decreased appetite—Methotrexate—germ cell cancer	1.87e-05	0.000322	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—germ cell cancer	1.85e-05	0.00032	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—germ cell cancer	1.85e-05	0.000319	CcSEcCtD
Tretinoin—RARB—Gene Expression—H2AFZ—germ cell cancer	1.84e-05	0.000601	CbGpPWpGaD
Tretinoin—Pain—Methotrexate—germ cell cancer	1.84e-05	0.000317	CcSEcCtD
Tretinoin—NR0B1—Generic Transcription Pathway—MYC—germ cell cancer	1.82e-05	0.000596	CbGpPWpGaD
Tretinoin—Feeling abnormal—Methotrexate—germ cell cancer	1.77e-05	0.000305	CcSEcCtD
Tretinoin—RARA—Gene Expression—H2AFZ—germ cell cancer	1.76e-05	0.000576	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—H2AFZ—germ cell cancer	1.76e-05	0.000576	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SLC2A3—germ cell cancer	1.76e-05	0.000574	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Methotrexate—germ cell cancer	1.76e-05	0.000303	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—SLC22A3—germ cell cancer	1.73e-05	0.000565	CbGpPWpGaD
Tretinoin—Urticaria—Methotrexate—germ cell cancer	1.71e-05	0.000294	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—germ cell cancer	1.7e-05	0.000293	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—germ cell cancer	1.7e-05	0.000293	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.63e-05	0.000532	CbGpPWpGaD
Tretinoin—Hypersensitivity—Methotrexate—germ cell cancer	1.58e-05	0.000273	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—germ cell cancer	1.54e-05	0.000266	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—SLC2A3—germ cell cancer	1.53e-05	0.000502	CbGpPWpGaD
Tretinoin—Pruritus—Methotrexate—germ cell cancer	1.52e-05	0.000262	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—SLC22A3—germ cell cancer	1.51e-05	0.000494	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—MYC—germ cell cancer	1.47e-05	0.000481	CbGpPWpGaD
Tretinoin—Diarrhoea—Methotrexate—germ cell cancer	1.47e-05	0.000253	CcSEcCtD
Tretinoin—Dizziness—Methotrexate—germ cell cancer	1.42e-05	0.000245	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—CRABP1—germ cell cancer	1.41e-05	0.000461	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC2A3—germ cell cancer	1.39e-05	0.000455	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC22A3—germ cell cancer	1.37e-05	0.000448	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—AVP—germ cell cancer	1.37e-05	0.000448	CbGpPWpGaD
Tretinoin—Vomiting—Methotrexate—germ cell cancer	1.36e-05	0.000235	CcSEcCtD
Tretinoin—Rash—Methotrexate—germ cell cancer	1.35e-05	0.000233	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—germ cell cancer	1.35e-05	0.000233	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—MYC—germ cell cancer	1.34e-05	0.00044	CbGpPWpGaD
Tretinoin—Headache—Methotrexate—germ cell cancer	1.34e-05	0.000232	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.33e-05	0.000434	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—MYC—germ cell cancer	1.32e-05	0.000431	CbGpPWpGaD
Tretinoin—Nausea—Methotrexate—germ cell cancer	1.27e-05	0.00022	CcSEcCtD
Tretinoin—RARA—Generic Transcription Pathway—MYC—germ cell cancer	1.26e-05	0.000413	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—MYC—germ cell cancer	1.26e-05	0.000413	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.26e-05	0.000411	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CRABP1—germ cell cancer	1.23e-05	0.000403	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.15e-05	0.000377	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CRABP1—germ cell cancer	1.12e-05	0.000366	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.09e-05	0.000356	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.02e-05	0.000334	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.01e-05	0.000329	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.37e-06	0.000306	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC2A3—germ cell cancer	9.35e-06	0.000306	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC22A3—germ cell cancer	9.21e-06	0.000301	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—H2AFZ—germ cell cancer	9.19e-06	0.0003	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—MYC—germ cell cancer	8.78e-06	0.000287	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CRABP1—germ cell cancer	8.19e-06	0.000268	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC2A3—germ cell cancer	7.55e-06	0.000247	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CRABP1—germ cell cancer	7.51e-06	0.000245	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC22A3—germ cell cancer	7.43e-06	0.000243	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC2A3—germ cell cancer	7.38e-06	0.000241	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC22A3—germ cell cancer	7.26e-06	0.000237	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—germ cell cancer	7.08e-06	0.000231	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC2A3—germ cell cancer	6.97e-06	0.000228	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC22A3—germ cell cancer	6.86e-06	0.000224	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—germ cell cancer	6.59e-06	0.000215	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—germ cell cancer	6.48e-06	0.000212	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC2A3—germ cell cancer	6.39e-06	0.000209	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—germ cell cancer	6.35e-06	0.000208	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC22A3—germ cell cancer	6.29e-06	0.000206	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—germ cell cancer	6.09e-06	0.000199	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—germ cell cancer	6.09e-06	0.000199	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CRABP1—germ cell cancer	6.06e-06	0.000198	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CRABP1—germ cell cancer	5.92e-06	0.000194	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CRABP1—germ cell cancer	5.6e-06	0.000183	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A3—germ cell cancer	5.2e-06	0.00017	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CRABP1—germ cell cancer	5.13e-06	0.000168	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC22A3—germ cell cancer	5.12e-06	0.000167	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—germ cell cancer	4.87e-06	0.000159	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CRABP1—germ cell cancer	4.17e-06	0.000136	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.43e-06	0.000112	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.38e-06	0.00011	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—germ cell cancer	3.17e-06	0.000104	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CRABP1—germ cell cancer	2.75e-06	9e-05	CbGpPWpGaD
